You are not logged in.
This means
you CAN ONLY VIEW reports that were published prior to Tuesday, February 20, 2024.
You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
 MIDDAY BREAKOUTS REPORT - FRIDAY, APRIL 24TH, 2020
Previous Mid Day Report Next Mid Day Report >>>
|
|
DOW 23517.55 2.29 (0.01%) | NASDAQ 8524.38 29.63 (0.35%) | S&P 500 2802.46 4.66 (0.17%)
|
Time of Screening :
4/24/2020 12:07:51 PM Report Released :
4/24/2020 12:56:05 PM
Price is:
Above 52W High and Less Than 52W High
but within 15% of the 52 Week High
Volume Is:
At least 45% of 50 Day Average at
the time of the screening.
More details about this report...
At around
mid-way through each trading day we run
a screen against our database of
high-ranked stocks, searching for
possible buy candidates that are trading
at or near their 52-week high on above
average volume. The results of that
screen are split into the two sections
you see below. The first, titled
"TODAY's FEATURED STOCKS" shows stocks
that our experts have recently
identified as among the strongest candidates to
consider. Stocks highlighted in yellow
are the most timely and noteworthy, so
particular attention and prompt action
may be appropriate. The second section,
titled "TODAY's BREAKOUT SCREEN" shows
the remainder of stocks meeting today's
screen parameters. Our experts have
reviewed and included notes on these
stocks as well, but found that they may
not match up as favorably.
|
|
Y - Today's strongest
candidates
highlighted
by our staff
of experts.
|
|
G - Previously featured in
this report as yellow and
now may no longer be buyable
under the guidelines.
|
|
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(50 DAV) |
52 Wk Hi
% From Hi |
Date
Featured |
Price
Featured |
Pivot Point |
|
Max Buy |
EBS
- NYSE
Emergent Biosolutions
|
$72.10
|
+5.53
8.31%
|
$74.00
|
682,724
130.04% of 50 DAV
50 DAV is 525,000
|
$71.19
1.28%
|
4/24/2020 |
$72.10
|
PP = $73.99
MB = $77.69 |
Most Recent Note - 4/24/2020 12:32:13 PM
Y - Color code is changed to yellow with pivot point cited based on its December 2018 high. Gapped up hitting a new 52-week high and touched a new all-time high today. A gain and strong close above the pivot point backed by at least +40% above average volume may trigger a technical buy signal. Due to report Mar '20 earnings news on 4/30/20. Reported earnings +101% on +33% sales revenues for the Dec '19 quarter, its 2nd strong quarterly comparison versus the year ago period. Annual earnings history (A criteria) has improved following a downturn in FY '16.
There are no Featured Stock Updates™ available for this stock at this time. You may request one by clicking the Request a New Note link below
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NFLX
- NASDAQ
Netflix Inc
|
$424.82
|
-1.88
-0.44%
|
$427.17
|
4,482,531
48.74% of 50 DAV
50 DAV is 9,197,000
|
$449.52
-5.49%
|
4/13/2020 |
$393.60
|
PP = $393.62
MB = $413.30 |
Most Recent Note - 4/24/2020 12:44:28 PM
G - Churned heavy volume this week while hovering near its all-time high, extended from the previously noted base. Reported earnings +107% on +28% sales revenues for the Mar '20 quarter versus the year ago period. Disciplined investors avoid chasing stocks more than +5% above the prior high or pivot point. See the latest FSU analysis for more details and an annotated graph.
>>> The latest Featured Stock Update with an annotated graph appeared on 4/21/2020. Click here.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
 |
Symbol - Exchange - Industry Group
Company Name |
Last |
Chg |
Day
High |
52 WK Hi |
% From Hi |
Volume
% DAV |
DAV |
ACU
- AMEX - HEALTH SERVICES - Medical Instruments & Supplies
Acme United Corp
|
$21.25 |
-0.27
-1.26%
|
$21.71
|
$24.92
|
-14.73% |
7,750
59.62%
|
13,000
|
Most Recent Note for ACU - 4/24/2020 12:08:57 PM
Rebounded above its 50 and 200 DMA lines with recent gains. The past 3 quarterly comparisons through Mar '20 showed earnings increases above the +25% minimum guideline (C criteria) with sales revenues growth rate showing acceleration. Annual earnings (A criteria) history has been up and down, not a match with the fundamental guidelines of the fact-based investment system.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AGI
- NYSE - Mining-Gold/Silver/Gems
Alamos Gold Inc
|
$7.59 |
-0.09
-1.17%
|
$8.02
|
$8.03
|
-5.48% |
2,068,025
48.13%
|
4,297,000
|
Most Recent Note for AGI - 4/24/2020 12:09:22 PM
Gapped up on the prior session hitting a new 52-week high. Prior mid-day reports cautioned members - "Earnings history is not a match with the fact-based investment system's fundamental guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AKG
- AMEX - Mining-Gold/Silver/Gems
Asanko Gold Inc
|
$1.11 |
-0.03
-2.63%
|
$1.21
|
$1.28
|
-13.28% |
420,543
74.83%
|
562,000
|
Most Recent Note for AKG - 4/24/2020 12:11:29 PM
Reversed into the red on the prior session after hitting another new 52-week high. Repeatedly noted in prior mid-day reports during a recent spurt of volume-driven gains - "Fundamentals are sub par."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AU
- NYSE - METALS & MINING - Gold
Anglogold Ashanti Ads
|
$26.51 |
+0.21
0.80%
|
$27.63
|
$26.86
|
-1.30% |
2,504,441
52.50%
|
4,770,000
|
Most Recent Note for AU - 4/24/2020 12:15:23 PM
Rallied above previously stubborn resistance in the $23 area to hit new 52-week highs with recent gains. Rebounded above its 50 and 200 DMA lines when noted in the 4/09/20 mid-day report - "Reported strong Sep and Dec '19 earnings increases versus the year ago periods. Prior quarterly and annual earnings history is not a match with the fact-based investment system's fundamental guidelines (C and A criteria)."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BTG
- NYSE - Mining-Gold/Silver/Gems
B2Gold Corp
|
$5.10 |
-0.09
-1.73%
|
$5.38
|
$5.50
|
-7.27% |
6,118,237
54.35%
|
11,258,000
|
Most Recent Note for BTG - 4/24/2020 12:15:58 PM
Hitting a new 52-week high with 4 consecutive gains. Went through a deep pullback and rebounded impressively after prior mid-day reports repeatedly cautioned members - "Reported Dec '19 earnings +17% on +36% sales revenues. Quarterly earnings comparisons through the Sep '19 quarter have been below the +25% minimum guideline (C criteria)."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CABO
- NYSE - Telecom Svcs-Cable/Satl
Cable One Inc
|
$1,768.50 |
+22.73
1.30%
|
$1,773.83
|
$1,830.50
|
-3.39% |
22,952
49.90%
|
46,000
|
Most Recent Note for CABO - 4/24/2020 12:18:28 PM
Consolidating only -2.6% off its all-time high. Earnings increases were above the +25% minimum guideline (C criteria) in the 2 latest quarterly comparisons through Dec '19. Annual earnings (A criteria) history has been strong after a downturn in FY '15.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DRD
- NYSE - METALS & MINING - Gold
Drdgold Ltd Adr
|
$9.15 |
-0.04
-0.45%
|
$9.64
|
$9.69
|
-5.59% |
380,659
83.48%
|
456,000
|
Most Recent Note for DRD - 4/24/2020 12:23:19 PM
Held its ground stubbornly after spiking to a new 52-week high with a big volume-driven gain on 4/13/20. Found prompt support near its 200 DMA line in recent weeks. Recent quarterly comparisons through Dec '19 showed greatly improved sales revenues and strong earnings increases versus year ago losses. Fundamental concerns remain as when noted with caution in the 2/07/13 mid-day report - "This low-priced South African company in the Mining - Gold/Silver/Gems group has an erratic earnings history, not a match with the fact-based investment system's guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
EW
- NYSE - HEALTH SERVICES - Medical Appliances & Equipment
Edwards Lifesciences Cp
|
$221.49 |
+0.45
0.20%
|
$235.28
|
$247.64
|
-10.56% |
901,374
49.23%
|
1,831,000
|
Most Recent Note for EW - 4/24/2020 12:35:44 PM
Rebounding above its 200 DMA line with recent gains. Reported earnings +14% on +14% sales revenues for the Mar '20 quarter. Prior quarterly comparisons were not strong and stead above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) history has been very good.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GFI
- NYSE - METALS & MINING - Gold
Gold Fields Ltd Adr
|
$7.88 |
-0.11
-1.32%
|
$8.36
|
$8.48
|
-7.13% |
5,788,988
54.08%
|
10,704,000
|
Most Recent Note for GFI - 4/24/2020 12:37:12 PM
Gapped up on the prior session hitting multi-year highs. Prior mid-day reports cautioned - "This South African company in the Mining - Gold/Silver/Gems industry has shown erratic sales revenues and earnings history through the Dec '19 quarter. Up and down annual earnings (A criteria) history is a fundamental concern."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GMAB
- NASDAQ - Medical-Biomed/Biotech
Genmab A/S Ads
|
$23.96 |
+0.47
2.00%
|
$24.11
|
$25.42
|
-5.74% |
253,691
45.30%
|
560,000
|
Most Recent Note for GMAB - 4/24/2020 12:40:30 PM
Impressively rebounding toward its all-time high after an abrupt retreat. Noted with caution in the 2/21/20 mid-day report - "Reported earnings +75% on +135% sales revenues for the Dec '19 quarter. Prior history has not been a match with the fundamental guidelines of the fact-based investment system."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GOLD
- NYSE - METALS & MINING - Gold
Barrick Gold Corporation
|
$27.12 |
+0.38
1.42%
|
$27.67
|
$28.50
|
-4.84% |
14,073,105
57.12%
|
24,637,000
|
Most Recent Note for GOLD - 4/24/2020 12:41:58 PM
Powered to a new 52-week high and above its 2016 high with recent volume-driven gains. Rebounded impressively after an abrupt retreat from its 2/24/20 high. Prior mid-day reports noted - "The Jun, Sep, and Dec '19 quarterly comparisons showed greatly accelerating sales revenues and earnings growth above the +25% minimum earnings guideline (C criteria). Up and down annual earnings (A criteria) history is a flaw. It was dropped from the Featured Stocks list on 3/14/12."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
OSUR
- NASDAQ - DRUGS - Diagnostic Substances
Orasure Technologies Inc
|
$14.93 |
-0.52
-3.35%
|
$15.91
|
$15.93
|
-6.26% |
501,267
47.74%
|
1,050,000
|
Most Recent Note for OSUR - 4/24/2020 12:45:40 PM
Perched at its 52-week high following an impressive rebound from the March low ($5.23). Prior mid-day reports repeatedly noted - "Quarterly and annual earnings history (C and A criteria) is not a match with the fundamental guidelines of the fact-based investment system."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
QDEL
- NASDAQ - DRUGS - Diagnostic Substances
Quidel Corp
|
$131.04 |
+5.97
4.77%
|
$131.99
|
$130.50
|
0.41% |
490,233
82.25%
|
596,000
|
Most Recent Note for QDEL - 4/24/2020 12:50:04 PM
Spiked to new all-time highs with recent gain backed by greater volume conviction. This San Diego, CA based maker of rapid diagnostic tests for infectious diseases has earned a high Earnings Per Share rating of 95. Reported earnings +23% on +15% sales revenues for the Dec '19 quarter and prior quarterly earnings comparisons were below the +25% minimum guideline (C criteria). Annual earnings (A criteria) history include a slight downturn in FY '19 following strong earnings growth in FY '17 and '18.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TSCO
- NASDAQ - SPECIALTY RETAIL - Specialty Retail, Other
Tractor Supply Co
|
$99.05 |
+3.97
4.18%
|
$99.29
|
$114.25
|
-13.30% |
888,475
48.13%
|
1,846,000
|
Most Recent Note for TSCO - 4/24/2020 12:54:14 PM
Rebounding above its 200 DMA line toward its all-time high. Reported earnings +13% on +8% sales revenues for the Mar '20 quarter, and prior quarterly comparisons were below the +25% minimum guideline (C criteria). Annual earnings history has been steady. It was dropped from the Featured Stocks list on 6/01/12.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TW
- NASDAQ - Financial Svcs-Specialty
Tradeweb Markets Cl A
|
$52.40 |
-0.12
-0.23%
|
$52.95
|
$55.27
|
-5.19% |
611,823
56.39%
|
1,085,000
|
Most Recent Note for TW - 4/24/2020 12:54:41 PM
Proposed a new Public Offering on 4/20/20 while perched near its 52-week high following an impressive rebound. Reported earnings +44% on +10% sales revenues for the Dec '19 quarter. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Limited history remains a concern since its $27 IPO on 4/04/19 and an additional Public Offering on 10/17/19.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ZM
- NASDAQ - Computer Sftwr-Enterprse
Zoom Video Comm Cl A
|
$175.76 |
+6.67
3.94%
|
$181.50
|
$169.75
|
3.54% |
13,885,173
99.62%
|
13,938,000
|
Most Recent Note for ZM - 4/24/2020 12:55:15 PM
Hitting another new all-time high with today's 2md consecutive gap up and big volume-driven gain. Found prompt support at its 50 DMA line following an abrupt retreat. The deep "V" shaped pullback was not a sound base pattern. Completed its $36.00 IPO on 4/18/19. Limited annual history (A criteria) is a concern. Reported earnings +275% on +78% sales revenues for the Jan '20 quarter. Prior quarterly comparisons also showed very strong sales revenues and great earnings increases versus the year ago periods.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
We are not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to FactBasedInvesting.com c/o Premium
Member Services 665 S.E. 10 Street, Suite 201
Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.
We appreciate any feedback
members may wish to send via the inquiry form
here.
|
|
|
